PRIMECAP MANAGEMENT CO/CA/ – Abiomed, Inc. Transaction History
PRIMECAP MANAGEMENT CO/CA/ portfolio value:
$370.03M
portfolio value
PRIMECAP MANAGEMENT CO/CA/ quarter portfolio value change:
-0.75%
quarter
Abiomed, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -2.14% | -32.98K shares | -10.94M | $245.66 | 1.50M |
Q2 2022 | share | Decrease | -4.43% | -71.36K shares | -152.51M | $247.51 | 1.53M |
Q1 2022 | share | Decrease | -3.42% | -57.02K shares | -65.46M | $331.24 | 1.61M |
Q4 2021 | share | Decrease | -7.38% | -132.86K shares | 12.86M | $362.06 | 1.66M |
Q3 2021 | share | Decrease | -3.03% | -56.3K shares | 6.57M | $325.52 | 1.80M |
Q2 2021 | share | Decrease | -3.19% | -61.28K shares | -31.82M | $312.11 | 1.85M |
Q1 2021 | share | Decrease | -6.34% | -129.79K shares | -52.57M | $318.73 | 1.91M |
Q4 2020 | share | Decrease | -7.91% | -175.98K shares | 47.77M | $324.2 | 2.04M |
Q3 2020 | share | Decrease | -15.85% | -418.97K shares | -22.26M | $277.06 | 2.22M |
Q2 2020 | share | Decrease | -9.63% | -281.53K shares | 213.90M | $241.56 | 2.64M |
Q1 2020 | share | Decrease | -5.14% | -158.49K shares | -101.40M | $145.16 | 2.92M |
Q4 2019 | share | Decrease | -0.10% | -3K shares | -23.03M | $170.59 | 3.08M |
Q3 2019 | share | Decrease | -1.44% | -45.2K shares | -266.66M | $177.89 | 3.08M |
Q2 2019 | share | Decrease | -0.57% | -18K shares | -83.72M | $260.49 | 3.13M |
Q1 2019 | share | Decrease | -2.51% | -81.2K shares | -150.62M | $285.59 | 3.14M |
Q4 2018 | share | Decrease | -4.20% | -141.7K shares | -466.57M | $325.04 | 3.23M |
Q3 2018 | share | Decrease | -5.33% | -190K shares | 59.51M | $449.75 | 3.37M |
Q2 2018 | share | Decrease | -6.82% | -260.75K shares | 344.64M | $409.05 | 3.56M |
Q1 2018 | share | Decrease | -6.29% | -256.7K shares | 347.84M | $290.99 | 3.82M |
Q4 2017 | share | Decrease | -3.28% | -138.5K shares | 53.38M | $187.41 | 4.07M |
Q3 2017 | share | Decrease | -4.88% | -216.19K shares | 75.73M | $168.6 | 4.21M |
Q2 2017 | share | Decrease | -4.37% | -202.50K shares | 54.90M | $143.3 | 4.43M |
Q1 2017 | share | Decrease | -0.86% | -40.04K shares | 53.53M | $125.2 | 4.63M |
Q4 2016 | share | Decrease | -0.68% | -31.96K shares | -78.46M | $112.68 | 4.67M |
Q3 2016 | share | Decrease | -5.95% | -297.9K shares | 58.27M | $128.58 | 4.70M |
Q2 2016 | share | Decrease | -9.55% | -528.8K shares | 22.35M | $109.29 | 5.00M |
Q1 2016 | share | Decrease | -2.15% | -121.8K shares | 14.07M | $94.81 | 5.53M |